Biopsy is a procedure of removal of tissues from the body part to examine whether the tissue or a tumour is cancerous or to determine the cause of an unexplained infection or inflammation. A biopsy is mostly used for diagnosis of cancers. Hence, removal of tissue or cell for analysis is called as biopsy. Most of the biopsy procedures are pain free and minimal risk. There are several types of biopsy including bone marrow biopsy, endoscopic biopsy, needle biopsy and skin biopsy. Biopsies are performed with imaging guidance such as ultrasound, x-ray, computed tomography (CT) and magnetic resonance imaging (MRI).
In the future, the global biopsy devices market growth is predicted to boost due to increasing research & development, technological advancement, awareness about cancers and rising prevalence for minimally invasive surgeries. However, risk associated with infection and bleeding and increasing rate of complex biopsy methods are the major restraining factor that are hindering the growth of the biopsy device market.
The report analyses the biopsy devices market based on product, application, end user and geography.
Based on product type the biopsy device market is categorized into needle-based biopsy instruments, procedure trays, localization wires and other products including brushes, curettes and punches. The needle-based biopsy instruments segment is further classified into core biopsy devices, aspiration biopsy needles and vacuum-assisted biopsy devices. The needle-based biopsy instruments segment accounted for largest market share and is estimated to account for highest CAGR during the forecast period. Factors such as lower risk associated with the use of needle and increasing demand for needle-based biopsy as compared to open surgery biopsy will ensure the healthy growth of the market in the future.
The report analysis the market based on application into breast biopsy, lung biopsy, colorectal biopsy, prostate biopsy and other including cardiac biopsy. The breast biopsy segment registered for highest market share in the global market. The overall growth of the biopsy devices market with respect to breast biopsy is primarily driven by increasing incidences and rising awareness of breast cancer in the developed and developing countries.
Based on end user, the global biopsy device market is categorized into hospitals, academic & research institutes and diagnostic & Imaging Centres. Among these segments, hospitals segment accounted for largest share in the market. The largest share of this segment can be primarily attributed to full range of services provided that includes surgery to intensive care, increasing number of hospitals and rising number of biopsy procedures in the hospital.
By geography biopsy devices market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and Middle East & Africa. North America accounted for largest share in the global biopsy device market and is expected to be the fastest-growing region during the prediction period owing to growing occurrence and frequency of cancer and technologically advancement in the healthcare sector in the region. Moreover, Asia Pacific is an attractive market for biopsy devices owing to the rapid development in the healthcare infrastructure of emerging economies like China and India coupled with increasing healthcare expenditure is likely to boost the market in the region.
Some of the key participants in the biopsy devices market are C. R. Bard, Inc, Becton, Dickinson and Company, Cook Group, Devicor Medical Products, Inc. (A Part of Leica Biosystems), ARGON MEDICAL, B. Braun Melsungen AG, Cardinal Health, Olympus Corporation, Boston Scientific Corporation, FUJIFILM Holdings Corporation, INRAD Inc, Medtronic, Hologic Inc, etc. Hologic Inc offers a Sertera biopsy device which is available in multiple gauge sizes. It is lightweight which makes the device a perfect choice for core needle biopsies. Additionally, new product development, Innovation, Research & development and partnership are the prominent strategies implemented by the global biopsy device market players to reinforce their position in the global market.
Why to buy this report: